Regeneron Pharmaceuticals Market Sentiment

Regeneron Pharmaceuticals Inc

REGNNASDAQ

Trade with Public

$827.72

-15.75-1.87%

近くで: Sep 4, 5:00 PM EST

$827.72

N/A

時間外: Sep 4, 4:15 PM EST

概要ニュース業績予想イベント目標株価財務センチメント株主構成配当比較オプション株式レポート

Regeneron Pharmaceuticals Market Sentiment

Market sentiment signals for Regeneron Pharmaceuticals (REGN): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 2.5% short float

Options Flow▼ 1.76 P/C ratio

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

31 analysts

Options Flow (P/C)

1.76

More puts — Bearish

312 calls · 549 puts

Avg Consensus PT

$797

-3.8%

Highest Price Target

$1030

+24.4%

Guggenheim

Lowest Price Target

$185

-77.6%

Benchmark

Short Interest

2.5%

Declining — Bullish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 17, 2026	Leerink Partners	David Risinger—	-0.4%	$641 → $824	Maintained	Market Perform
Aug 3, 2026	Citigroup	Geoff Meacham—	-10.6%	$700 → $740	Maintained	Neutral
Aug 3, 2026	Guggenheim	Brad Canino—	+24.4%	$1000 → $1030	Maintained	Buy
Jul 31, 2026	RBC Capital	Brian Abrahams—	-11.0%	$696 → $737	Maintained	Sector Perform
Jul 31, 2026	Morgan Stanley	Matthew Harrison—	-8.4%	$730 → $758	Maintained	Equal-Weight
Jul 31, 2026	Cantor Fitzgerald	Carter Gould—	-4.0%	$750 → $795	Maintained	Overweight
Jul 31, 2026	Wells Fargo	Mohit Bansal—	-9.4%	$700 → $750	Maintained	Equal-Weight
Jul 31, 2026	Truist Securities	Gregory Renza—	-6.7%	$769 → $772	Maintained	Buy
Jul 21, 2026	Guggenheim	Brad Canino—	+20.8%	$995 → $1000	Maintained	Buy
Jul 9, 2026	Piper Sandler	Biren Amin—	+3.2%	$855 → $854	Maintained	Overweight
Jul 8, 2026	Morgan Stanley	Matthew Harrison—	-11.8%	$788 → $730	Maintained	Equal-Weight
Jul 7, 2026	RBC Capital	Brian Abrahams—	-15.9%	$707 → $696	Maintained	Sector Perform
Jul 7, 2026	Truist Securities	Gregory Renza—	-7.1%	$778 → $769	Maintained	Buy
Jul 7, 2026	Benchmark	Robert Wasserman—	-77.6%	$185	Upgrade	Hold→Buy
Jul 6, 2026	HSBC	Rajesh Kumar—	+6.3%	$990 → $880	Maintained	Buy
Jul 6, 2026	Cantor Fitzgerald	Carter Gould—	-9.4%	$785 → $750	Maintained	Overweight
May 19, 2026	Canaccord Genuity	John Newman—	+5.7%	$1057 → $875	Maintained	Buy
May 18, 2026	BMO Capital	Evan David Seigerman—	-11.8%	$900 → $730	Maintained	Outperform
May 18, 2026	Truist Securities	Gregory Renza—	-6.0%	$796 → $778	Maintained	Buy
May 18, 2026	JP Morgan	Chris Schott—	+2.7%	$950 → $850	Maintained	Overweight
May 18, 2026	Piper Sandler	Biren Amin—	+3.3%	$875 → $855	Maintained	Overweight
May 18, 2026	Wells Fargo	Mohit Bansal—	-15.4%	$800 → $700	Maintained	Equal-Weight
May 18, 2026	RBC Capital	Brian Abrahams—	-14.6%	$762 → $707	Maintained	Sector Perform
May 18, 2026	Citigroup	Geoff Meacham—	-15.4%	$900 → $700	Downgrade	Buy→Neutral
May 18, 2026	Leerink Partners	Andrew Berens—	-22.6%	$792 → $641	Downgrade	Outperform→Market Perform